CClinicalTrials.gg
CompletedNCT06024902Updated Dec 22, 2023

Clinical Characteristics of Severe Childhood Asthma

An observational study in Severe Asthma, sponsored by Children's Hospital of Fudan University. Completed at 1 site in China. Open to participants aged 6 Years to 17 Years. Per ClinicalTrials.gov, last updated 2023-12-22.

Sponsored by Children's Hospital of Fudan University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
650
Ages
6 Years to 17 Years
Sex
All
01

Study summary

Asthma remains a serious health problem with increasing prevalence and incidence. There is limited information about severe asthma among Chinese pediatric patients. In this context, we decided to explore the clinical characteristics and risk factors of severe asthma in children. This is a descriptive, observational, retrospective cohort study in children with asthma.

The purpose of this retrospective study is: to determine the clinical characteristics of severe asthma of children; to identify the factors associated with severe childhood asthma.

Read the detailed description

Asthma remains a serious health problem with increasing prevalence and incidence. There is limited information about severe asthma among Chinese pediatric patients. In this context, we decided to explore the clinical characteristics and risk factors of severe asthma in children. This is a descriptive, observational, retrospective cohort study in children with asthma.

The purpose of this retrospective study is: to determine the clinical characteristics of severe asthma of children; to identify the factors associated with severe childhood asthma.

Participants were consecutively recruited from asthma clinics between January 2021 and December 2021 at Children's Hospital of Fudan University. Patients fulfilling the following criteria were eligible for inclusion: (1) aged 6-17 years old; (2) diagnosed with asthma according to the Global Initiative for Asthma (GINA) 2020 guideline; (3) children and their caregivers are informed and voluntarily join the database and had follow up for at least 1 year. Patients who had cystic fibrosis, mechanical airway obstruction, or any other pulmonary disease or whose parents or legal guardians were not able to fill in the questionnaires were not enrolled.

At baseline, the asthma specialist questioned each of the patient in the presence of their caregivers to ensure that they supplied accurate disease information and were included according to the criteria. The patients and their caregivers are asked to complete the online questionnaires including the demographic; baseline asthma control, triggers, exacerbation, medication and adherence; environmental exposure, and diagnosis and control of comorbidities, etc. If a patient had poorly controlled comorbidities, multidisciplinary consultation would be recommended. Clinical assessments were arranged at baseline, 3, 6, 9, and 12 months.

02

Conditions studied

  • Severe Asthma

Browse trials for

03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 506 are open to participants now.

This study's enrollment of 650 is above the median of 150 across 970 observational studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

Children's Hospital of Fudan University is the lead sponsor of 262 studies on the registry; 92 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The tertiary specialized children's hospital

Inclusion criteria

  • (1) aged 6-17 years old;
  • (2) diagnosed with asthma according to the Global Initiative for Asthma (GINA) 2020 guideline;
  • (3) children and their caregivers are informed and voluntarily join the database and had follow up for at least 1 year.

Exclusion criteria

Exclusion Criteria:

  • (1) Patients with cystic fibrosis;
  • (2) had mechanical airway obstruction, or any other pulmonary disease;
  • (3) whose parents or legal guardians were not able to fill in the questionnaires.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
650 participants (actual)
Patient registry
No

Groups and cohorts

  • childhood asthma

    Subjects with confirmed diagnosis of asthma without other lung disease followed for collection of demographic and clinical data.

06

What researchers measure

Primary outcomes

  1. Severity of asthma

    The severity of asthma was comprehensively estimated by a pediatric pulmonologist following the criteria of the Global Initiative for Asthma (GINA) 2021(collecting clinical characteristics, questionnaires and Pulmonary function tests)when patients completed 12-months management.

    Time frame: 12 months

07

Study locations

1 site
  • Children's Hospital of Fudan University
    Shanghai, Shanghai 201102, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06024902
Lead sponsor
Children's Hospital of Fudan University
Responsible party
Sponsor
First posted
Sep 6, 2023
Start date
Jan 1, 2021
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Dec 22, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion